The link between the drug industry and the "super bacteria"

Recently, a new type of "super bacteria" frequently appeared in the domestic and foreign media, and even had a case of death after the patient's infection. It has been reported that the current effective for the super bacteria is mainly for hoop and slime.　　Affected by this news, the Union drug Industry (600513) Nearly 4 days of continuous trading, trading volume yesterday was a new high since the company's listing.　　But today, the joint pharmaceutical Industry issued a clarification notice saying that the company has a small sales of the product sales share, almost negligible; the emergence of "super bacteria" will not make the company's production of sulfate tablets of extraordinary growth, will not have a significant impact on the company's recent manufacturing operations.　　The joint pharmaceutical industry comprehensive recent report on "Super bacteria" to verify that the media coverage is true, but the market rumors are inaccurate. Linked to the pharmaceutical industry, sulfate is the company's old products, since the early 80 the beginning of production, its clinical application is mainly to treat children with intestinal infections, such as diarrhea, dysentery and other diseases.　　Because of the choice of drugs in this area, the drug sales in recent years is very small, the share of the company's products are almost negligible. The Union pharmaceutical industry also said that the current carrying so-called "super bacteria" in the number of patients, only in a few countries found, and did not have an outbreak of the epidemic, the domestic also did not find the same case. At the same time, for the media to report "Super bacteria", the domestic medical and health authorities have not been confirmed. As a result, there is no real commercial demand for drugs that inhibit "superbugs", and with further research into the "superbugs" in the international pharmaceutical community, more drugs are believed to be able to inhibit the bacteria.